HCS Pharma is pleased to present the whole range of BIOMIMESYS® Products.
All our scientific team is ready to support you in using our 3D organ/tissue-specific cell-culture technology.
Rediscover your cells in real in vitro 3D-culture conditions with our special evaluation plate format .
You can find our presentation in PDF format with this link
For more information, contact us at hello@biomimesys.com
Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.
Last week HCS Pharma was pleased to take part to Elrig Uk Research & Innovation. This event took place on the 20 and 21 March in Manchester. It was a great opportunity to share another Read more…
The annual “Research and Innovation” congress by ELRIG UK will take place on 20 and 21 March in Manchester. We are delighted to participate in this event with a poster presentation and a booth in Read more…
RIKEN, equivalent to CNRS in France, is a national research and development agency based in Japan and is the largest comprehensive research institution in the country. After RIKEN symposium held in Belgium on February 14 Read more…
1 Comment
New 384-well plates format for BIOMIMESYS® Liver & Oncology entitling Cell-Based Assays High-Throughput Screening | HCS Pharma · November 26, 2020 at 2:01 pm
[…] BIOMIMESYS® 3D cell culture systems and obtain more predictive in vitro […]